Diamyd Medical will install a new Cytiva FlexFactory platform in Umeå, Sweden. Once up and running, the clinical-stage biopharmaceutical company will begin manufacturing its precision-medicine vaccine. The first of its kind, the type-1 diabetes vaccine works to reprogram immune cells to prevent the destruction of pancreatic insulin-producing B-cells.
.
